| scholarly article | Q13442814 |
| P50 | author | Ramon Brugada | Q1546186 |
| Josep Brugada | Q1706299 | ||
| Georgia Sarquella-Brugada | Q51135420 | ||
| Oscar Campuzano | Q42767334 | ||
| Anna Fernandez-Falgueras | Q87982784 | ||
| P2860 | cites work | Evaluation of genes encoding for the transient outward current (Ito) identifies the KCND2 gene as a cause of J-wave syndrome associated with sudden cardiac death | Q43590861 |
| A missense mutation in the sodium channel β2 subunit reveals SCN2B as a new candidate gene for Brugada syndrome. | Q44515706 | ||
| Assessment of QT intervals and prevalence of short QT syndrome in Japan. | Q44781039 | ||
| Role of HCN4 channel in preventing ventricular arrhythmia | Q45804174 | ||
| Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population | Q46301151 | ||
| Mutation in the KCNQ1 gene leading to the short QT-interval syndrome | Q47438291 | ||
| Structural myocardial abnormalities in asymptomatic family members with Brugada syndrome and SCN5A gene mutation | Q47892963 | ||
| Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. | Q50980218 | ||
| Increase in sudden death from coronary artery disease in young adults. | Q51050406 | ||
| Clinical and electrocardiographic characteristics of patients with short QT interval in a large hospital-based population. | Q51424203 | ||
| MOG1: a new susceptibility gene for Brugada syndrome. | Q51485064 | ||
| Autopsy investigation and Bayesian approach to coronary artery disease in victims of motor-vehicle accidents. | Q51559295 | ||
| MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia | Q22009462 | ||
| Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death | Q24294267 | ||
| A cardiac arrhythmia syndrome caused by loss of ankyrin-B function | Q24295030 | ||
| Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak | Q24296910 | ||
| A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene | Q24297875 | ||
| Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias | Q24298971 | ||
| KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation | Q24299782 | ||
| Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death | Q24300356 | ||
| Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome | Q24300388 | ||
| Mutation of an A-kinase-anchoring protein causes long-QT syndrome | Q24304235 | ||
| Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human | Q24307681 | ||
| Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex | Q24308697 | ||
| Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome | Q24308735 | ||
| Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans | Q24310498 | ||
| Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias | Q24311437 | ||
| SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome | Q24314276 | ||
| Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death | Q24315099 | ||
| A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome | Q24316980 | ||
| Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death | Q34241382 | ||
| Sudden death associated with short-QT syndrome linked to mutations in HERG. | Q34283788 | ||
| Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features | Q34333434 | ||
| Diagnostic criteria for the long QT syndrome. An update | Q34351752 | ||
| Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. | Q34395488 | ||
| Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival | Q34445532 | ||
| CALM3 mutation associated with long QT syndrome | Q34451319 | ||
| Cardiac ion channels | Q34516208 | ||
| Cellular basis of drug-induced torsades de pointes | Q34786459 | ||
| The QT syndromes: long and short | Q34818456 | ||
| Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. | Q35566050 | ||
| Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study. | Q35661823 | ||
| Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort | Q35691043 | ||
| Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8 | Q35782882 | ||
| Large Genomic Imbalances in Brugada Syndrome. | Q36148081 | ||
| Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels. | Q36216295 | ||
| Molecular physiology of cardiac repolarization | Q36267771 | ||
| The congenital long QT syndromes from genotype to phenotype: clinical implications | Q36335249 | ||
| Epidemiology and stratification of risk for sudden cardiac death | Q36383698 | ||
| Bidirectional tachycardia in a child. A study using His bundle electrography | Q36822217 | ||
| Novel Timothy syndrome mutation leading to increase in CACNA1C window current | Q37002976 | ||
| Characterization of SEMA3A-encoded semaphorin as a naturally occurring Kv4.3 protein inhibitor and its contribution to Brugada syndrome | Q37002977 | ||
| Essential features of designating out-of-hospital cardiac arrest as a reportable event: a scientific statement from the American Heart Association Emergency Cardiovascular Care Committee; Council on Cardiopulmonary, Perioperative, and Critical Care; | Q37138820 | ||
| Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome | Q37140014 | ||
| Calmodulin mutations associated with recurrent cardiac arrest in infants | Q37327429 | ||
| The molecular autopsy: an indispensable step following sudden cardiac death in the young? | Q37367786 | ||
| Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia | Q37396920 | ||
| FGF12 is a candidate Brugada syndrome locus | Q37407989 | ||
| Prevalence of the congenital long-QT syndrome. | Q37442080 | ||
| Sudden death: managing the patient who survives. | Q37928855 | ||
| Sudden cardiac death caused by coronary heart disease | Q37988837 | ||
| Cardiac sodium channel NaV1.5 distribution in myocytes via interacting proteins: the multiple pool model | Q38057534 | ||
| HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. | Q38134931 | ||
| Negative autopsy and sudden cardiac death. | Q38188482 | ||
| The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases. | Q38197734 | ||
| Utility of the exercise electrocardiogram testing in sudden cardiac death risk stratification. | Q38231499 | ||
| Postmortem molecular screening in unexplained sudden death. | Q38447893 | ||
| Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype | Q39130495 | ||
| Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. | Q40355175 | ||
| Can antiarrhythmic drugs survive survival trials? | Q40863654 | ||
| Post-mortem genetic analysis in juvenile cases of sudden cardiac death. | Q41758739 | ||
| The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization | Q41772555 | ||
| Sex difference in risk of torsade de pointes with d,l-sotalol | Q42552460 | ||
| Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. | Q43073409 | ||
| Drug-induced QT prolongation in women during the menstrual cycle | Q43545871 | ||
| Nonsense-mediated mRNA decay due to a CACNA1C splicing mutation in a patient with Brugada syndrome | Q43580608 | ||
| SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome | Q24317024 | ||
| Mutations in the hminK gene cause long QT syndrome and suppress IKs function | Q24323571 | ||
| Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations | Q24529526 | ||
| Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test | Q24607414 | ||
| Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome | Q24655604 | ||
| Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death | Q24675134 | ||
| Catecholaminergic Polymorphic Ventricular Tachycardia | Q28076072 | ||
| Current topics in catecholaminergic polymorphic ventricular tachycardia | Q28076784 | ||
| Identification of a Kir3.4 mutation in congenital long QT syndrome | Q28114943 | ||
| Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism | Q28117072 | ||
| Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6) | Q28117761 | ||
| Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome | Q28118648 | ||
| Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia | Q28201561 | ||
| A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel | Q28204838 | ||
| Desmosomes and the sodium channel complex: implications for arrhythmogenic cardiomyopathy and Brugada syndrome | Q28236522 | ||
| Genetic basis and molecular mechanism for idiopathic ventricular fibrillation | Q28265902 | ||
| Catecholaminergic polymorphic ventricular tachycardia | Q28287523 | ||
| Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death | Q28294931 | ||
| K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current | Q28295470 | ||
| Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia | Q28299768 | ||
| Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype | Q28304358 | ||
| Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel | Q28485378 | ||
| A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. | Q29347544 | ||
| Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks | Q29347555 | ||
| Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop | Q30433543 | ||
| Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. | Q33147854 | ||
| Proposed diagnostic criteria for the Brugada syndrome: consensus report | Q33148286 | ||
| Short QT Syndrome: a familial cause of sudden death | Q33149259 | ||
| Congenital deaf-mutism, prolonged QT interval, syncopal attacks and sudden death | Q33149692 | ||
| A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN | Q33150169 | ||
| RARE CARDIAC ARRYTHMIAS OF THE PEDIATRIC AGE. II. SYNCOPAL ATTACKS DUE TO PAROXYSMAL VENTRICULAR FIBRILLATION. (PRESENTATION OF 1ST CASE IN ITALIAN PEDIATRIC LITERATURE) | Q33150208 | ||
| Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations | Q33151146 | ||
| Short QT syndrome | Q33152684 | ||
| Gain-of-function KCNH2 mutations in patients with Brugada syndrome. | Q51750593 | ||
| Sex differences in the evolution of the electrocardiographic QT interval with age | Q52415294 | ||
| Incidence of sudden cardiac death in China: analysis of 4 regional populations. | Q53777625 | ||
| Testing the burden of rare variation in arrhythmia-susceptibility genes provides new insights into molecular diagnosis for Brugada syndrome | Q55422968 | ||
| A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22 | Q55843608 | ||
| Catecholaminergic Polymorphic Ventricular Tachycardia | Q55983198 | ||
| Sudden Death in Young Adults | Q56554682 | ||
| Muerte súbita | Q57235785 | ||
| Drug-Induced Prolongation of the QT Interval | Q57580883 | ||
| 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death | Q57626293 | ||
| Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity | Q58011214 | ||
| Sex differences in phenotypic manifestation and gene transmission in the Romano-Ward syndrome | Q58011347 | ||
| Electrical alternation of the T-wave: Clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome | Q58011829 | ||
| Idiopathic short QT interval: a new clinical syndrome? | Q59286850 | ||
| A missense mutation in the sodium channel β1b subunit reveals SCN1B as a susceptibility gene underlying long QT syndrome | Q62105574 | ||
| Clínica y genética en el síndrome de QT largo | Q62671102 | ||
| Spironolactone and Metabolic Acidosis | Q66914789 | ||
| Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene | Q68298471 | ||
| ECG T-Wave Patterns in Genetically Distinct Forms of the Hereditary Long QT Syndrome | Q71807499 | ||
| Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes | Q73265460 | ||
| KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome | Q73914726 | ||
| Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients | Q75404578 | ||
| Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia | Q78390804 | ||
| Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) | Q79845488 | ||
| Exclusion of multiple candidate genes and large genomic rearrangements in SCN5A in a Dutch Brugada syndrome cohort | Q80446672 | ||
| Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population | Q80749905 | ||
| Multiple source surveillance incidence and aetiology of out-of-hospital sudden cardiac death in a rural population in the West of Ireland | Q81118957 | ||
| Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls | Q81684580 | ||
| Drug induced shortening of the QT/QTc interval: an emerging safety issue warranting further modelling and evaluation in drug research and development? | Q82205802 | ||
| Long QT Syndrome | Q82207682 | ||
| A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS | Q82712227 | ||
| Dynamic change in ST-segment and spontaneous occurrence of ventricular fibrillation in Brugada syndrome with a novel nonsense mutation in the SCN5A gene during long-term follow-up | Q82930778 | ||
| Brugada syndrome caused by a large deletion in SCN5A only detected by multiplex ligation-dependent probe amplification | Q83353831 | ||
| Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts | Q83513616 | ||
| Catecholaminergic Polymorphic Ventricular Tachycardia | Q87379298 | ||
| Brugada syndrome | Q88086487 | ||
| Short QT syndrome. Genotype-phenotype correlations | Q33153179 | ||
| The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome | Q33153549 | ||
| Short QT syndrome: clinical findings and diagnostic-therapeutic implications | Q33154179 | ||
| Long QT syndrome and pregnancy | Q33154884 | ||
| The Long QT Syndrome | Q33155336 | ||
| Clinical practice. Long-QT syndrome | Q33155879 | ||
| Clinical and molecular genetics of the short QT syndrome | Q33156151 | ||
| The long QT syndrome. Prospective longitudinal study of 328 families | Q33156679 | ||
| Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome | Q33157277 | ||
| The short QT syndrome: proposed diagnostic criteria. | Q33159709 | ||
| Long-term follow-up of patients with short QT syndrome | Q33160301 | ||
| Arrhythmic risk in congenital long QT syndrome | Q33160438 | ||
| Brugada syndrome 2012. | Q33161523 | ||
| A study of the SCN5A gene in a cohort of 76 patients with Brugada syndrome. | Q33161757 | ||
| The long Q-T syndrome | Q33162456 | ||
| Practical issues in the management of the long QT syndrome: focus on diagnosis and therapy | Q33163342 | ||
| Brugada syndrome 1992-2012: 20 years of scientific excitement, and more | Q33163480 | ||
| Novel calmodulin mutations associated with congenital arrhythmia susceptibility | Q33164413 | ||
| Novel SCN10A variants associated with Brugada syndrome | Q33165566 | ||
| Short QT Syndrome - Review of Diagnosis and Treatment | Q33166770 | ||
| Idiopathic long QT syndrome: progress and questions | Q33170127 | ||
| Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients | Q33173888 | ||
| Evidence of genetic heterogeneity in Romano-Ward long QT syndrome. Analysis of 23 families | Q33174006 | ||
| Molecular genetic aspects of the Romano-Ward long QT syndrome | Q33174174 | ||
| Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs | Q33174249 | ||
| Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. | Q33175663 | ||
| Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperature | Q33311598 | ||
| Sudden cardiac death with normal heart: molecular autopsy | Q33348909 | ||
| A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype | Q33572315 | ||
| An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing | Q33655317 | ||
| Cardiac sodium channelopathies | Q33906972 | ||
| PQ segment depression in patients with short QT syndrome: a novel marker for diagnosing short QT syndrome? | Q33942230 | ||
| Brugada syndrome: report of the second consensus conference. | Q33987201 | ||
| Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? | Q34202001 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P577 | publication date | 2017-01-29 | |
| P1433 | published in | Biology | Q17509951 |
| P1476 | title | Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic Advances | |
| P478 | volume | 6 |
| Q92409590 | CPVT: Arrhythmogenesis, Therapeutic Management, and Future Perspectives. A Brief Review of the Literature |
| Q58578140 | Epilepsy in patients with long QT syndrome type 1: A Norwegian family |
| Q89433762 | Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists |
| Q39345477 | Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes. |
| Q60920696 | Impact of Ancestral Differences and Reassessment of the Classification of Previously Reported Pathogenic Variants in Patients With Brugada Syndrome in the Genomic Era: A SADS-TW BrS Registry |
| Q49574372 | Incomplete Penetrance and Variable Expressivity: Hallmarks in Channelopathies Associated with Sudden Cardiac Death |
| Q52679005 | Ion Channel Disorders and Sudden Cardiac Death. |
| Q41220043 | Limitations of galactose therapy in phosphoglucomutase 1 deficiency |
| Q89530614 | Non-diagnostic autopsy findings in sudden unexplained death victims |
| Q90619103 | Polyunsaturated fatty acid analogues differentially affect cardiac Nav, Cav, and Kv channels through unique mechanisms |
| Q92025079 | R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndrome |
| Q58699168 | Recent Advances in Short QT Syndrome |
| Q33873348 | Recent advances in the management of ventricular tachyarrhythmias. |
| Q91961805 | Short QT Syndrome: A Comprehensive Genetic Interpretation and Clinical Translation of Rare Variants |
| Q59796614 | Sudden Death in Young Brazilian Athletes: Isn't It Time We Created a Genuinely National Register? |
| Q41392147 | Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies. |
| Q92815378 | The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases |
| Q93035290 | miR-1, miR-499 and miR-208 are sensitive markers to diagnose sudden death due to early acute myocardial infarction |
Search more.